Affinage

FARP2

FERM, ARHGEF and pleckstrin domain-containing protein 2 · UniProt O94887

Length
1054 aa
Mass
119.9 kDa
Annotated
2026-06-09
38 papers in source corpus 8 papers cited in narrative 8 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 6/6 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

FARP2 (FRG) is a FERM domain-containing Dbl-family guanine nucleotide exchange factor for the Rho GTPases Rac1 and Cdc42 that converts multiple cell-surface signals into localized cytoskeletal remodeling (PMID:16286926, PMID:15277544). Its GEF activity is intrinsically held off: crystal structures of the DH and DH-PH-PH module show an autoinhibited conformation in which the substrate-binding site is occluded by the terminal DH helix and the two PH domains, and disrupting these elements relieves suppression in cells (PMID:23375260). This autoinhibited pool is recruited to signaling platforms and released by defined upstream cues. In semaphorin signaling, FARP2 basally associates with plexin-A1; Sema3A binding to neuropilin-1 triggers FARP2 dissociation, activating its Rac GEF activity, promoting Rnd1 recruitment and R-Ras downregulation, while its FERM domain sequesters PIPKIgamma661 from talin to drive axonal repulsion (PMID:16286926). Through a distinct interaction with the KRK motif of PlxnA4, FARP2 mediates Sema3A-induced Rac1 activation selectively for dendritic morphogenesis (PMID:32499377). At nectin-based adherens junctions, c-Src recruits and tyrosine-phosphorylates FARP2 to locally activate Cdc42 (PMID:15277544), and aPKCι binds and phosphorylates FARP2 to form a positive-feedback loop driving epithelial polarity and tight junction formation (PMID:30872454). Beyond neurons and epithelia, FARP2 supports localized Rac1 activation in osteoclast podosomes during bone resorption (PMID:20702777) and is required for TGF-β1-driven myofibroblast differentiation (PMID:41786192).

Mechanistic history

Synthesis pass · year-by-year structured walk · 8 steps
  1. 2004 High

    Established FARP2 as a Cdc42-specific GEF that is recruited and activated at cell-cell adhesion sites, linking nectin/Src signaling to junction assembly.

    Evidence Co-IP, RNAi, GEF and tyrosine-phosphorylation assays at nectin-based junctions

    PMID:15277544

    Open questions at the time
    • Did not resolve how Src-mediated phosphorylation structurally relieves autoinhibition
    • Selectivity between Cdc42 and Rac in this context not fully defined
  2. 2005 High

    Defined FARP2 as the Rac GEF released from plexin-A1 upon Sema3A/neuropilin-1 engagement, coupling a guidance receptor to bifunctional Rac activation and talin/PIPKIgamma sequestration in axon repulsion.

    Evidence Reciprocal Co-IP, biochemical dissociation and GEF assays, axon repulsion functional readouts

    PMID:16286926

    Open questions at the time
    • Mechanism triggering dissociation from plexin-A1 at atomic resolution unknown
    • Relative contribution of GEF activity versus PIPKIgamma sequestration not quantified
  3. 2006 Medium

    Placed FARP2 downstream of CD47/Src as a contributor to Cdc42/Rac activation supporting neuronal process development.

    Evidence FRG inhibition, CD47 overexpression, autophosphorylation assays and neuronal morphology in hippocampal neurons

    PMID:17135401

    Open questions at the time
    • Relied on inhibition rather than clean loss-of-function
    • Functional redundancy with Vav2 not dissected
    • Single lab
  4. 2010 High

    Extended FARP2's role beyond neurons by showing it drives localized Rac1 activation in osteoclast podosomes required for resorption and osteoclastogenesis.

    Evidence Live imaging, GTP-Rac1 pull-down, knockdown/knockout osteoclasts, resorption pit assay

    PMID:20702777

    Open questions at the time
    • Upstream receptor recruiting FARP2 to podosomes not identified
    • Link to integrin β3 activation mechanistically incomplete
  5. 2013 High

    Provided the structural basis for FARP2 regulation, showing intramolecular autoinhibition of the GEF active site by the DH and tandem PH domains.

    Evidence X-ray crystallography of DH and DH-PH-PH modules with cell-based GEF activity validation

    PMID:23375260

    Open questions at the time
    • Structure of the activated, signal-released state not determined
    • How phosphorylation or receptor binding triggers the conformational switch unresolved
  6. 2019 High

    Identified FARP2 as an aPKCι binding partner and phosphorylation substrate forming a positive-feedback loop that activates Cdc42 to drive epithelial polarity and tight junction formation.

    Evidence Co-IP, phosphorylation assay, siRNA, GTP-Cdc42 pull-down, polarity and junction assays

    PMID:30872454

    Open questions at the time
    • How phosphorylation-induced detachment couples to Cdc42 loading not structurally defined
    • In vivo relevance of the feedback loop not tested
  7. 2020 High

    Resolved pathway specificity by showing FARP2 binds the PlxnA4 KRK motif to mediate Sema3A-induced Rac1 activation for dendrite morphogenesis while being dispensable for axon growth cone collapse.

    Evidence CRISPR/Cas9 KRK knock-in mice, FARP2 loss-of-function, Rac1 activity assays, dendritic and axon guidance readouts in vivo and in vitro

    PMID:32499377

    Open questions at the time
    • What distinguishes the plexin-A1 versus PlxnA4 FARP2 pools mechanistically unclear
    • Effector specificity for dendrite versus axon outcomes not fully explained
  8. 2026 Medium

    Implicated FARP2 in pathological tissue remodeling, showing it is induced by TGF-β1 and required for myofibroblast differentiation and migration in corneal stromal fibroblasts.

    Evidence siRNA knockdown, qPCR, Western blot, α-SMA immunocytochemistry, scratch migration assay

    PMID:41786192

    Open questions at the time
    • No in vivo confirmation of a role in corneal fibrosis
    • GTPase effector mediating the fibrotic phenotype not directly demonstrated
    • Single lab

Open questions

Synthesis pass · forward-looking unresolved questions
  • How the structurally defined autoinhibited state is converted to the active state by the diverse upstream inputs (plexin release, Src and aPKCι phosphorylation) remains unresolved at the mechanistic level.
  • No structure of an activated/receptor-bound FARP2 state
  • Quantitative rules for Rac1 versus Cdc42 selectivity across contexts undefined

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0098772 molecular function regulator activity 3
Localization
GO:0005886 plasma membrane 2
Pathway
R-HSA-162582 Signal Transduction 3 R-HSA-1266738 Developmental Biology 2 R-HSA-1500931 Cell-Cell communication 2

Evidence

Reading pass · 8 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2005 FARP2 directly associates with plexin-A1 in the presence of neuropilin-1. Sema3A binding to neuropilin-1 induces dissociation of FARP2 from plexin-A1, resulting in activation of FARP2's Rac GEF activity, Rnd1 recruitment to plexin-A1, and downregulation of R-Ras. Simultaneously, the FERM domain of FARP2 sequesters PIPKIgamma661 from talin, inhibiting its kinase activity. Both activities are required for Sema3A-mediated axonal repulsion and suppression of neuronal adhesion. Co-immunoprecipitation, GEF activity assays, biochemical dissociation assays, functional axon repulsion assays Nature neuroscience High 16286926
2004 FRG (FARP2) functions as a GDP/GTP exchange factor specific for Cdc42. At nectin-based cell-cell adhesion sites, nectins recruit and activate c-Src, which then recruits FRG, tyrosine phosphorylates it, and activates it, leading to local Cdc42 activation and adherens junction formation. RNAi depletion of FRG suppressed nectin-induced Cdc42 activation. Co-immunoprecipitation, RNAi knockdown, GEF activity assay, tyrosine phosphorylation assay The Journal of cell biology High 15277544
2006 FRG (FARP2), alongside Vav2, mediates CD47-induced activation of Cdc42 and Rac in hippocampal neurons downstream of Src, promoting dendrite and axon development. Inhibition of FRG prevented CD47-promoted dendritic development. Inhibition of FRG (dominant negative/pharmacological), overexpression of CD47, autophosphorylation assays, morphological analysis of hippocampal neurons The Journal of neuroscience Medium 17135401
2010 FARP2 is required for localized activation of Rac1 (GTP-bound form) into podosome-ring-like structures in osteoclasts, and is relevant to integrin β3 activity during osteoclastogenesis. FARP2 deficiency reduces formation of multinucleated osteoclasts and resorption pits. Live cell imaging, biochemical GTP-Rac1 pull-down assays, FARP2 knockdown/knockout osteoclasts, functional resorption pit assay FASEB journal High 20702777
2013 Crystal structures of the DH and DH-PH-PH domains of FARP2 reveal an autoinhibited conformation in which the GEF substrate-binding site is blocked collectively by the last helix of the DH domain and the two PH domains, stabilized by multiple inter-domain interactions. Cell-based activity assays confirmed suppression of FARP2 GEF activity by these autoinhibitory elements. X-ray crystallography, cell-based GEF activity assays Structure High 23375260
2019 FARP2 is a RIPR motif-dependent binding partner and phosphorylation substrate of aPKCι. The interaction is mediated by a FERM/FA domain–kinase domain interface, and aPKCι-dependent phosphorylation promotes detachment of FARP2. FARP2 promotes GTP loading of Cdc42, consistent with upstream regulation of the PAR6-aPKCι polarity complex. aPKCι-mediated phosphorylation of FARP2 acts as a positive feedback loop to drive polarisation and tight junction formation. Co-immunoprecipitation, phosphorylation assay, siRNA knockdown, GTP-Cdc42 pull-down, cell polarity and junction formation assays Journal of cell science High 30872454
2020 FARP2 binds to the KRK motif in the PlxnA4 cytoplasmic domain and mediates Sema3A-induced Rac1 activation specifically for dendritic elaboration of cortical neurons, but is dispensable for Sema3A-mediated axon growth cone collapse. This defines a Sema3A-Nrp1/PlxnA4/FARP2/Rac1 pathway selectively controlling dendrite morphogenesis. CRISPR/Cas9 knock-in mice (KRK motif mutation), FARP2 loss-of-function, Rac1 activity assays, dendritic morphology and axon guidance assays in vivo and in vitro The Journal of neuroscience High 32499377
2026 TGF-β1 upregulates FARP2 expression in corneal stromal fibroblasts; FARP2 knockdown suppresses TGF-β1-induced upregulation of RHOA, TLN1, SLC2A4, and COL1A1, reduces α-SMA expression (myofibroblast marker), and markedly reduces cell migration in scratch assay, indicating FARP2 is required for TGF-β1-mediated myofibroblast differentiation and corneal fibrosis. siRNA knockdown, real-time PCR, Western blotting, immunocytochemistry (α-SMA), scratch/wound healing assay International journal of biological macromolecules Medium 41786192

Source papers

Stage 0 corpus · 38 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2005 FARP2 triggers signals for Sema3A-mediated axonal repulsion. Nature neuroscience 186 16286926
2004 Activation of Cdc42 by trans interactions of the cell adhesion molecules nectins through c-Src and Cdc42-GEF FRG. The Journal of cell biology 91 15277544
1992 mRNP4, a major mRNA-binding protein from Xenopus oocytes is identical to transcription factor FRG Y2. The Journal of biological chemistry 82 1629179
2006 CD47 promotes neuronal development through Src- and FRG/Vav2-mediated activation of Rac and Cdc42. The Journal of neuroscience : the official journal of the Society for Neuroscience 68 17135401
1995 Gastroprotective activity of FRG-8813, a novel histamine H2-receptor antagonist, in rats. Japanese journal of pharmacology 67 7563973
1993 Gastric antisecretory effect of FRG-8813, a new histamine H2 receptor antagonist, in rats and dogs. European journal of pharmacology 54 8099553
2017 Efficacy of hepatitis B virus ribonuclease H inhibitors, a new class of replication antagonists, in FRG human liver chimeric mice. Antiviral research 35 29129708
2010 Integral roles of a guanine nucleotide exchange factor, FARP2, in osteoclast podosome rearrangements. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 34 20702777
2009 FARP2, HDLBP and PASK are downregulated in a patient with autism and 2q37.3 deletion syndrome. American journal of medical genetics. Part A 34 19365831
2013 Structural basis for autoinhibition of the guanine nucleotide exchange factor FARP2. Structure (London, England : 1993) 32 23375260
2010 Facioscapulohumeral muscular dystrophy region gene-1 (FRG-1) is an actin-bundling protein associated with muscle-attachment sites. Journal of cell science 32 20215405
2020 Modular and Distinct Plexin-A4/FARP2/Rac1 Signaling Controls Dendrite Morphogenesis. The Journal of neuroscience : the official journal of the Society for Neuroscience 31 32499377
2024 Identifying novel mechanisms of per- and polyfluoroalkyl substance-induced hepatotoxicity using FRG humanized mice. Archives of toxicology 17 38782768
1996 Stimulation of mucin biosynthesis in rat gastric mucosa by FRG-8813 and its structural analogs. European journal of pharmacology 17 8851171
1983 Creatine kinase variants. Report on the workshop conference of the German Society for Clinical Chemistry held on September 19 to 21, 1982 in Tübingen, FRG. Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie 17 6663246
1994 Effects of the new histamine H2 receptor antagonist, FRG-8813, on gastric mucin in rats with or without acidified ethanol-induced gastric damage. Life sciences 16 7509019
1992 [Effects of FRG-8813, a new type histamine H2-receptor antagonist, on various experimental gastric and duodenal lesions in rats]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica 16 1356897
2023 Characterization of the humanized FRG mouse model and development of an AAV-LK03 variant with improved liver lobular biodistribution. Molecular therapy. Methods & clinical development 15 36700121
2023 PreS1- targeting chimeric antigen receptor T cells diminish HBV infection in liver humanized FRG mice. Virology 15 37478771
2019 The Rho family GEF FARP2 is activated by aPKCι to control tight junction formation and polarity. Journal of cell science 15 30872454
2008 Farp2 and Stk25 are candidate genes for the HDL cholesterol locus on mouse chromosome 1. Arteriosclerosis, thrombosis, and vascular biology 14 18988887
2000 Effect of FRG-8813, a new-type histamine H(2)-receptor antagonist, on the recurrence of gastric ulcer after healing by drug treatment in rats. Pharmacology 13 10940781
2014 Troglitazone metabolism and transporter effects in chimeric mice: a comparison between chimeric humanized and chimeric murinized FRG mice. Xenobiotica; the fate of foreign compounds in biological systems 12 24417752
2001 Flavin specificity and subunit interaction of Vibrio fischeri general NAD(P)H-flavin oxidoreductase FRG/FRase I. Archives of biochemistry and biophysics 12 11469801
1995 [Studies on histamine H2-receptor antagonistic property of FRG-8813, a novel anti-ulcer drug]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica 8 7774860
1990 Effects of FRG-8701 on gastric acid secretion, gastric mucosal lesions by necrotizing agents and experimental gastric or duodenal ulcer in rats. Japanese journal of pharmacology 7 1982548
1978 Frequency, serodiagnosis and epidemiological features of subacute sclerosing panencephalitis (SSPE) and epidemiology and vaccination policy for measles in the Federal Republic of Germany (FRG). Developments in biological standardization 7 381072
1981 Friend murine leukemia virus resistance in Japanese wild mice: possible allelism with Fv-4 in FRG mice. Journal of the National Cancer Institute 6 6939918
1992 [Effects of FRG-8813, a new-type histamine H2-receptor antagonist, on the healing of gastric and duodenal ulcer in rats and spontaneously ulcerative mice]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica 5 1356898
2022 Efficient engraftment and viral transduction of human hepatocytes in an FRG rat liver humanization model. Scientific reports 4 35982097
1995 [Effect of FRG-8813, a new histamine H2-receptor antagonist, on gastric mucus production in rats]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica 4 8582686
1991 Classical and modern methods of cerebrospinal fluid analysis. Report on the First All-German Symposium of the Society for Laboratory Medicine (FRG) and the Study Group for CSF Analysis and Clinical Neurochemistry of the Society for Psychiatry and Neurology (formerly GDR) in Marburg a. d. Lahn, October 5-6, 1990. European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 4 1764547
1982 ["Abnormal reaction" or cultural misunderstandings? A contribution to the improvement of medical care to children of migrant labourers in the FRG (author's transl)]. Klinische Padiatrie 4 7062688
2023 Recapitulation of Skewed X-Inactivation in Female Ornithine Transcarbamylase-Deficient Primary Human Hepatocytes in the FRG Mouse: A Novel System for Developing Epigenetic Therapies. Human gene therapy 3 37350098
1985 Optical properties and structure of tetrapyrroles. A report of a symposium held at the University of Konstanz, FRG, August 12-17, 1984. FEBS letters 2 4007161
1994 [Effects of FRG-8813, a new histamine H2-receptor antagonist, on gastric mucus in rats]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica 1 7829023
2026 Pivotal role of FARP2 in TGF-β1-mediated myofibroblast differentiation and corneal fibrosis. International journal of biological macromolecules 0 41786192
1998 The novel histamine H2 receptor antagonist FRG-8813 prevents delay of wound repair induced by hydrogen peroxide in a rabbit gastric epithelial cell system. Journal of gastroenterology and hepatology 0 28976655

Missed literature

Know a paper Affinage missed for FARP2? Flag it for the maintainers and the community.

No submissions yet.